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Background: Duchenne Muscular Dystrophy (DMD) is an X-linked recessive disorder with its primary insult on the
skeletal muscle. Severe muscle wasting, chronic inflammation and fibrosis characterize dystrophic muscle. Here we
identify dysregulated pathways in DMD utilizing a co-expression network approach as described in Weighted Gene Co-
expression Network Analysis (WGCNA). Specifically, we utilize WGCNA’s “preservation” statistics to identify gene
modules that exhibit a weak conservation of network topology within healthy and dystrophic networks. Preservation
statistics rank modules based on their topological metrics such as node density, connectivity and separability between
networks.
Methods: Raw data for DMD was downloaded from Gene Expression Omnibus (GSE6011) and suitably preprocessed.
Co-expression networks for each condition (healthy and dystrophic) were generated using the WGCNA library in R.
Preservation of healthy network edges was evaluated with respect to dystrophic muscle and vice versa using WGCNA.
Highly exclusive gene pairs for each of the low preserved modules within both networks were also determined using a
specificity measure.
Results: A total of 11 and 10 co-expressed modules were identified in the networks generated from 13 healthy and 23
dystrophic samples respectively. 5 out of the 11, and 4 out of the 10 modules were identified as exhibiting none-to-
weak preservation. Functional enrichment analysis identified that these weakly preserved modules were highly relevant
to the condition under study. For instance, weakly preserved dystrophic module D2 exhibited the highest fraction of
genes exclusive to DMD. The highly specific gene pairs identified within these modules were enriched for genes
activated in response to wounding and affect the extracellular matrix including several markers such as SPP1, MMP9
and ITGB2.
Conclusion: The proposed approach allowed us to identify clusters of genes that are non-randomly associated with
the disease. Furthermore, highly specific gene pairs pointed to interactions between known markers of disease and
identification of putative markers likely associated with disease. The analysis also helped identify putative novel
interactions associated with the progression of DMD.
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Duchenne muscular dystrophy (DMD), is a lethal form
of dystrophinopathy characterized by marked deficiency
or absence of subsarcolemmal cytoskeletal protein- dys-
trophin. Absence of this protein is caused due to frame
shift mutations of the dystrophin gene [1]. Dystrophin,
part of the dystroglycan complex plays a crucial role in
maintaining the integrity of the muscle fiber. Absence of
dystrophin causes uneven mechanical force transmissions
leading to sarcolemmal ruptures and subsequent atrophy.
Clinical manifestations of DMD occur by second year of
birth and progressively degrade with time. The first dec-
ade of life is marked by developmental delays, and steady
decreases in the strength of the limbs and torso with sub-
sequent loss of ambulation. Respiratory and cardiac com-
plications arise by the second decade of life leading to
death [2]. Here we utilize a co-expression networks ap-
proach to gain insights into molecular interactions dysreg-
ulated in dystrophic skeletal muscle with respect to
healthy muscle.
Co-expression networks are being increasingly used for
deciphering disease mechanisms and providing systems
level views of dysregulated pathways [3,4]. The basic prem-
ise of co-expression analysis is that strongly correlated
genes are likely to be functionally associated. Weighted
Gene Co-expression Network Analysis (WGCNA) is an
open source tool that performs co-expression analysis using
a network theoretic approach. WGCNA integrates expres-
sion differences across samples into a higher order network
structure, elucidating relationships among genes based on
their co-expression profiles [5,6].
Here, we propose to utilize a set of statistics imple-
mented in WGCNA, called preservation statistics, to elu-
cidate global differences in mechanisms underlying the
early phase of DMD [7]. Traditionally, these statistics have
been utilized to identify modules of genes that are topo-
logically preserved between two networks. In contrast to
this approach, we propose to utilize these statistics to
identify modules that do not exhibit a preservation of top-
ology between networks. This is based on the premise that
such modules would represent a cohort of gene interac-
tions that are vastly different between conditions and
point to dysfunctional pathways and interactions.
In our current study we utilize a previously published
dataset on DMD containing a cohort of healthy and af-
fected individuals (mostly children) - representing the
early phase of DMD development [8]. Briefly, we evalu-
ated differential mechanisms between dystrophic and
healthy skeletal muscle using the following approach;
first, co-expression networks were generated independ-
ently for healthy and dystrophic samples; second, clus-
tering each of the co-expression networks resulted in
several groups of biologically relevant genes (modules)
for each condition; and finally, preservation of modulartopology from one condition was detected with respect
to the second condition, allowing us to identify differ-
ences in gene connectivity patterns between conditions.
The results of our differential analysis reveal conver-
gent molecular mechanisms consistent with published
studies in addition to providing us novel hypothesis on
gene interactions associated with the early phase of
DMD.
Results and discussion
Network construction and modularity detection
WGCNA was utilized to construct unsigned weighted
co-expression networks from 13 healthy and 23 DMD
muscle samples across 4000 most varying genes (see
Methods). Briefly, unsigned network adjacency matrices
were obtained by raising the Pearson correlation matri-
ces to a power β =5 for each condition [5]. The adjacen-
cies were transformed to similarity matrices for
subsequent clustering. When represented as networks,
each entry of the similarity matrix ij corresponds to
weight on the edge between genes ij. The strength of
similarity between two genes depends not only on the
correlation but also on their shared network neighbor-
hood [5]. Clustering based on such a similarity allowed
for identification of gene groups that were biologically
relevant.
Hierarchical clustering of the two weighted networks
resulted in eleven modules for the network from
healthy samples (N1-N11, see Methods) and ten
modules from the network derived from dystrophic
samples (D1-D10, see Methods). Additional file 1
shows the clustering dendrograms and corresponding
modules identified in both networks. Genes that did
not cluster were excluded from further analysis for the
purposes of this study.
Functional characterization of modules identified in
healthy and dystrophic networks
Modules identified using WGCNA have been repeatedly
shown to be biological relevant to the condition under
study [4,9]. We utilized functional enrichment analysis
as a method to assess the functional coherence of mod-
ules identified within each of the networks.
Characterizing modules of the healthy network
Enrichment of modules from the healthy network re-
vealed several functions routinely associated with healthy
skeletal muscle such as striated muscle contraction, en-
ergy generation and extracellular matrix organization
(Table 1).
Skeletal muscle contraction occurs via the coordinated
movement of several proteins particularly the actin-
myosin complex within the sarcomere, incident upon a
changing Ca2+ flux. Several genes encoding the sarcomeric
Table 1 Enrichment of modules identified in the healthy network
Module #Nodes Top Term p value
N1 590 striated muscle contraction 7.59E-07
N2 323 extracellular structure organization 2.90E-08
N3 109 actin cytoskeleton organization 1.50E-02
N4 598 modification-dependent macromolecule catabolic process 2.36E-04
N5 349 intracellular protein transport 7.69E-06
N6 93 generation of precursor metabolites and energy 8.27E-39
N7 215 chromatin assembly or disassembly 8.06E-04
N8 125 muscle organ development 3.74E-03
N9 171 fatty acid metabolic process 3.85E-05
N10 1102 intracellular protein transport 5.12E-05
N11 319 ribosomal small subunit biogenesis 4.28E-05
This table represents the top functional enrichment term from the highest ranking annotation cluster identified for each module of the healthy network. The
annotation clusters were ranked and identified using DAVID’s annotation clustering tool [31] [see Additional file 6].
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TPM3, TNNC1/2, TNNI1, TNNT1, MYOM2, MYOZ1,
MYOZ2, and MYOZ3 were identified in modules N1 and
N8 [10]. The extracellular matrix (ECM) surrounding the
skeletal muscle plays an important role in force transmis-
sion and affects the mechanical properties of the skeletal
muscle. Several genes associated with the ECM and focal
adhesion such as COL4A1, COL4A2, COL5A2, COL6A1,
COL6A2, ITGA6, ITGB1, CAV1, CTNNB1, ACTB and
LAMN4 were identified in modules N1 and N8 [11].
Muscle contraction and relaxation depend primarily upon
energy derived from hydrolysis of adenosine triphosphate
(ATP) within the mitochondria. Glycogen/glucose and
lipid metabolism serve as major sources of ATP within
muscle. Several genes associated with such metabolism
were identified within modules N6 and N9 with genes
such as NDUFB3, NDUFB5, FABP4, AACS, ADIPOQ,
SDHA, SDHB and SCD.Table 2 Enrichment of modules identified in the dystrophic n
Module #Nodes Top Term
D1 247 cytoskeleton or
D2 156 response to wo
D3 121 blood vessel de
D4 377 modification-de
D5 540 ubiquitin-depen
D6 874 generation of p
D7 180 muscle system
D8 301 RNA splicing
D9 75 extracellular ma
D10 1089 positive regulat
This table represents the top functional enrichment from the highest ranking annot
annotation clusters were ranked and identified using DAVID’s annotation clusteringCharacterizing modules of the dystrophic network
Though the same 4000 genes were used to construct the
co-expression network in each case, modules cluster dif-
ferently based on their co-expression. Subsequent en-
richment of modules from the dystrophic network
revealed functions particularly associated with dys-
trophic muscle such as response to wounding (Table 2).
For instance, module D2 contained several genes asso-
ciated with wounding and inflammatory response, in-
cluding several cathepsins and MHC class II antigen
processing and presentation genes such as HLA-DPA1,
HLA-DMA, HLA-DPB1, HLA-DQA1, HLA-DRA, and
HLA-DRB1 [12]. Chronic inflammatory processes are
known to initiate fibrosis within dystrophic muscle [13].
Concurrently, ECM adapts dramatically altering both
the manifestation and function within dystrophic
muscle. We observe the co-expression of ECM markers





pendent macromolecule catabolic process 1.56E-03
dent protein catabolic process 5.24E-04




ion of ligase activity 9.73E-05
ation cluster identified for each module of the diseased network. The
tool [31] [see Additional file 7].
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collagen expression within this module [14].
Modules D4 and D5 were associated with apoptosis
and proteolytic processes within the muscle - more spe-
cifically ubiquitin-proteosome system [15] with genes
such as genes of the 23 s proteasome (PSMA2/3,
PSMD9/12, PSME2/4), ubiquitin conjugating enzymes
(UBE2B, UBE2D1), ubiquitin ligases (UBE3A, UBE3C),
ubiquitin peptidases (USP11, USP6) co-expressed with
cullins (CUL4A and CUL5) that serve as scaffolds for
ubiquitin ligases.
Identifying functional differences between healthy and
dystrophic muscle- a systems approach
The functional annotation clustering results above sug-
gested a mutual exclusivity of certain functions between
dystrophic and healthy muscle implying a difference in
the topology of connections for genes within these
networks.
In order to systematically assess and quantify differen-
tial gene co-expression, we performed a “preservation”
analysis. This allowed us to identify modules that were
fairly unique in terms of their gene co-expression within
a given network compared to another. We utilized a
method implemented in WGCNA called “modulePreser-
vation” [7]. In contrast to the idea of the original paper
which aimed at identifying modules preserved between
conditions, we aimed to identify modules “weakly pre-
served” across conditions (see Methods). We hypothe-
sized that modules that were either weakly preserved orFigure 1 Differential co-expression in healthy muscle with respect to dystrop
between test (dystrophic) and reference (healthy) networks. B: Co-expression
a subset of genes identified within module N1 are shown here. All interaction
co-expression between the gene pairs.non-preserved in either condition might point to dysreg-
ulated pathways in disease that were either acquired or
lost with respect to a healthy skeletal muscle.
Assessing differential co-expression in healthy muscle with
respect to dystrophy
In order to evaluate how the topology of the healthy net-
work differed from the dystrophic network, we com-
puted the preservation (density, connectivity and
separability statistics) of modules from the healthy net-
work (reference network) as compared to the dystrophic
network (test network). Lower preservation statistics
suggested a loss of co-expression structure between
these gene pairs in the dystrophic network.
Based on the median preservation score, we identified
a total of 5 interesting modules. Two modules N1 and
N8 from the healthy network were non-preserved in the
dystrophic network while three other modules N2, N3
and particularly N7 exhibited weak preservation
(Figure 1A). A table of the observed preservation statis-
tics for all modules of the healthy network is provided in
Additional file 2. Zsummary, a permutation statistic (see
Methods) defined for assessing significance of the ob-
served preservation also revealed a low preservation of
these modules (Table 3). Broadly, loss of healthy muscle
function and weakened contractility in dystrophic
muscle triggers the activation of atrophic pathways lead-
ing to severe muscle wasting, changes to the extracellu-
lar matrix, fibrosis and necrosis over time [16].
Accordingly, unpreserved modules N1 and N8 werehy. A: Scatter plot identifying the median rank of module preservation
between genes identified in module N1- The co-expression patterns for
s have a specificity of >0.95. Darker the line, stronger is the strength of
Table 3 Permutation based Zsummary
Module Size Median rank Z summary log p values
(Z summary)
N1 590 12 6.03 −13.80
N2 323 8 9.66 −29.99
N3 109 8 5.25 −8.66
N4 598 4 23.84 −139.55
N5 349 6 15.97 −71.44
N6 93 2 10.69 −27.93
N7 215 9 5.53 −9.57
N8 125 12 2.33 −2.69
N9 171 5 10.26 −28.77
N10 1102 1 51.15 −581.53
N11 319 3 18.85 −91.87
This table reports the composite measure Zsummary and its associated p-value
obtained by permuting modules labels in the dystrophic (test) network to
assess preservation of modules in the healthy network. Median rank based on
the observed statistics are also reported here. Data for modules identified as
being weakly preserved are shown in bold.
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traction, while the weakly preserved modules (N2, N3
and N7) were associated with ECM and cytoskeletal
framework of the skeletal muscle.
We utilized a co-expression specificity measure [17]
(see Methods) to elucidate co-expressed genes pairs
(edges) from these 5 modules. We observed that mod-
ules exhibiting none-to-low preservation in the healthy
network consistently had a higher fraction of gene pairs
exclusive to the healthy network than their preserved
counterparts (Table 4). For instance, ~35% of the gene
pairs considered (599/1738) within N1 were specific to
the healthy network (Figure 1B). Several of the genesTable 4 Healthy network specificity- this table represents
the fraction of edges identified as being exclusive to the
healthy modules as compared to the dystrophic network
Module Name #Genes (n) #Gene pairs considered Gene pair
specificity (%)
N1 590 1738 34.46
N2 323 520 15.00
N3 109 59 16.95
N4 598 1785 3.08
N5 349 607 2.31
N6 93 43 6.98
N7 215 230 16.09
N8 125 78 16.67
N9 171 145 4.83
N10 1102 6067 0.12
N11 319 507 2.37
#Gene pairs represent the top 1% of the edges calculated as 0.01*(n(n-1)/2).involved are known markers influencing skeletal muscle
contraction such as ANKRD2, TNNC2, SMAD3, HSPB1,
CRYAB, SDC4, and MYOD1.
It was interesting to observe however that a majority
of the genes identified as being part of these interactions
were ion- binding as per GO’s molecular function ontol-
ogy (zinc and copper, p < 10−4). A visual inspection of
subset of the exclusive genes pairs identified reveals
strong co-expression between several zinc binding genes
such as metallothioneins (MT1E/F/H/X), ZNF593, and
genes affecting muscle contraction (ANKRD1, MYOD1,
SMAD3, HSPB1). Metallothioneins have been postulated
to be associated with a host of functions ranging from
chaperones for synthesis of metalloproteins, to reservoirs
of essential metals (Zn and Cu) in healthy tissue [18].
Specifically, metallothioneins (MTs) exhibit specific
redox properties and have been speculated to selectively
control release and uptake of Zinc [18]. However, it is
interesting to note that MTs were co-expressed with
genes affecting muscle contraction only within the
healthy network, suggesting a link between zinc homeo-
stasis, and muscle contraction in healthy muscle. The
exclusivity of connections to the healthy network further
emphasizes the possibility of an aberration in zinc
homeostasis and its effect on contraction in DMD.
Assessing differential co-expression in dystrophic muscle
with respect to healthy tissue
A similar analysis with dystrophic network as the refer-
ence network, allowed us to identify gene pairs that were
not conserved in healthy tissue. As proposed earlier, we
speculated that identifying non/weakly preserved mod-
ules in the dystrophic network could point to gene asso-
ciations that are gained in dystrophy. We identified two
modules- D1 and D8 that exhibited no preservation in
the healthy network while two other modules D3 and to
a greater extent D2 were weakly preserved (Figure 2A).
A table of the observed preservation statistics for all
modules of the dystrophic network is provided in
Additional file 3. The Zsummary scores (see Methods)
likewise revealed a low preservation of these modules via
permutation testing (Table 5).
Juvenile dystrophic muscle, in general, exhibits atrophy
and is pre-necrotic, with pathways associated with
wounding and inflammation being subsequently acti-
vated. The functional enrichment identified within these
four modules (Table 2) corroborated our approach,
highlighting functions that are more pronounced in dys-
trophic muscle compared to healthy tissue.
These modules also exhibited higher specificity of con-
nections to the dystrophic network than their preserved
counterparts (Table 6). For instance, the highest specifi-
city was observed for module D2 with nearly 45% of its
gene pairs as being specific to dystrophy (specificity >
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tions identified in module D2 corresponded with inter-
actions categorized as a part of the inflammatory and
tissue repair/remodeling repertoire of genes, as wit-
nessed in models of skeletal muscle injury, particularly
dystrophy (Figure 2B).
For instance, expression of SPP1, a multifunctional
cytokine (also called early T-cell activation-1 (Eta-1),
osteopontin), is linked with macrophage infiltration,
resulting in a chronic inflammatory response observed in
dystrophic muscle [13,19]. VSIG4, a regulator of T-cell ac-
tivation expressed mostly in macrophages is strongly co-
expressed within D2 [19]. Though the exact mechanisms
by which skeletal muscle attracts and allows entry of neu-
trophils and macrophages in dystrophic muscle are not
well understood, there is evidence suggesting that ITGB2
is required to control the functional activities of neutro-
phils and macrophages within muscle [20]. Fibrosis ob-
served in DMD, is largely activated in response to chronic
inflammatory processes initiated within dystrophic muscle
[13] and broadly refers to the accumulation of excess con-
nective tissue (ECM) [11]. SPP1 which is also expressed in
fibrotic lesions is considered a marker for disease severity
in DMD [21]. SPP1 is required for differentiation of myo-
fibroblasts [22], an important class of fibroblastic cells re-
quired for wound healing, present abundantly within
dystrophic muscle. Fibronectin (FN1) serves as a marker
for fibroblast activation in muscle [23].
SPP1, in addition to modulating fibrotic responses,
promotes cell-cell and cell-matrix adhesions through itsFigure 2 Differential co-expression in dystrophic muscle with respect to he
preservation between test (healthy) and reference (dystrophic) networks. B
module D2 from the dystrophic network- For the same set of genes from
(left). The size of the node is proportional to the sum of all correlation stren
correlation and blue indicate negative correlation.interaction with integrins, and CD44 [24]. Mature focal
adhesion complexes containing genes such as ACTN1,
fail to form in the absence of SPP1 (SPP1−/−) within
myofibroblast cultures [22] suggesting similar pathways
for adhesion in dystrophy. Interestingly, within this
module we also identify MMP9- a matrix metallopro-
teinase whose increased expression, particularly in the
pathology of DMD, is associated with breakdown of
cytoskeleton-ECM components leading to sarcolemmal
damage and fiber necrosis [25,26] Additionally, MMP9
is also suggested to act as an inflammatory stimulus for
mediating neutrophil and macrophage infiltration within
the dystrophic skeletal muscle [27,28].
SPP1 is subject to extensive posttranslational modifica-
tion via glycosylation, phosphorylation and sulphation. Spe-
cific posttranslational modifications have been associated
with altered properties and function of SPP1 [29]. Interest-
ingly, ACP5, a phosphatase required for mineralization of
cartilage and bone matrix resorption [28] was recently
demonstrated to be responsible for phosphorylation of
SPP1 in endometrial tissue. Though no evidence for role of
ACP5 or post-translation modification of SPP1 in dys-
trophic muscle exists, the co-expression of ACP5 with
SPP1 suggests a possible role in dystrophy warranting fur-
ther investigation.
Additionally, SPP1 shows high specificity interactions
with certain ECM markers including CTSK, LUM,
VCAN and VIM (Figure 2B). Though there is no direct
evidence for the interaction of these markers with SPP1,
the extant understanding of the ECM markers combinedalthy muscle. A: Scatter plot identifying the median rank of module
: The Pearson correlation between a subset of genes identified in
module D2, we also identify correlation patterns in the healthy network
gths at the node in the network shown. Red lines indicate positive
Table 5 Permutation based Zsummary
Module Size Median rank Z summary log p values
(Z summary)
D1 247 11 2.50 −3.03
D2 156 9 2.35 −2.78
D3 121 8 7.36 −17.83
D4 377 2 16.89 −73.04
D5 540 4 20.28 −113.58
D6 874 7 18.91 −120.35
D7 180 5 9.60 −28.01
D8 301 11 5.36 −12.79
D9 75 5 4.80 −6.16
D10 1089 1 50.95 −568.57
This table reports the composite measure Zsummary and its associated p-value
obtained by permuting modules labels in the healthy (test) network to assess
preservation of modules in the dystrophic network. Median rank based on the
observed statistics are also reported here. Data for modules identified as being
weakly preserved are shown in bold.
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our network module suggest possible associations with
SPP1 in dystrophic muscle.
Overall, our results indicate that the modules exhibit-
ing low preservation statistics contain several gene pairs
that are likely to be associated with the disease progres-
sion. Though it is conceivable that not all the genes
identified within these less-preserved modules play a
role in disease, several high specificity gene pairs identi-
fied were noted and hypothesized to play a significant
role in pathogenesis of DMD.
Conclusions
An analysis of modules exhibiting a low preservation be-
tween dystrophic and healthy conditions showed that
these modules showed a higher specificity among gene
pairs pertinent to the condition under study. WeTable 6 This table lists the fraction of edges identified as
being exclusive to the dystrophic modules with respect
to the healthy network
Module Name #Genes #Gene pairs Specificity (%)
D1 247 304 20.39
D2 156 121 45.45
D3 121 73 4.11
D4 377 709 2.12
D5 540 1455 4.60
D6 874 3815 3.96
D7 180 161 3.11
D8 301 452 3.32
D9 75 28 0.00
D10 1089 5924 0.20
#Gene pairs represent the top 1% of the edges calculated as 0.01*(n(n-1)/2).illustrated the application of using preservation statistics
to detecting modules functionally associated with dys-
regulated pathways in disease, as exemplified by the in-
flammatory module D2. This approach enabled
identifying putative biomarkers, such as ACP5 identified
within module D2, likely to be associated with the
disease.
In summary, our method provided a simple approach
to identifying differences between conditions, which can
be utilized for exploratory analysis of dysregulated path-
ways in disease using a published set of statistics.
Methods
Data acquisition
The raw (.CEL) files for GSE6011 was downloaded from
GEO [30]. This data consists of 37 Affymetrix HG-
U133A microarrays with 24 juvenile DMD samples, be-
tween ages 1.5-61 months, and 13 age matched controls
[8].
Data processing
The data set was preprocessed using Bioconductor/R
packages affy and WGCNA. Data was MAS 5.0 normal-
ized using functions in affy and any array with an aver-
age inter sample correlation <2 SDs (σ) below the mean
was removed [9]. This resulted in the removal of a single
array - GSM139506.CEL (2.54 σ below mean) from the
study. All probes with missing Entrez gene identifiers
were excluded from this study, resulting in a data set
comprising of the expression values for 11101 probes.
Multiple probes were collapsed into a gene based on
variance resulting in a final reduced expression data set
comprising of 7996 genes and 36 samples. A subset of
4000 most varying genes was used to construct the co-
expression networks, in an effort to minimize computa-
tional complexity and eliminate low varying genes that
may contribute minimally to the co-expression matrix.
The number 4000 was chosen as it represents roughly
half the total number of genes (7996 genes) identified
after pre-processing. This method of gene list selection
is agnostic to their pathophysiological role in the
muscle.
Co-expression network generation and modularity
detection
The topological overlap measure (TOM) in WGCNA
between genes i and j is defined as follows
TOMij ¼
XN
k¼1Ai;k :Ak;j þ Ai;j
min ki;kj
 þ 1−Ai;j
Where A is the weighted adjacency matrix given by
Aij = |cor(xi,xj)|
β and β ≥ 1 is the soft thresholding power.
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0 for a gene pair indicates no similarity between the
genes while 1 indicates a direct link. The soft threshold-
ing power β for each dataset in our study was ascer-
tained as prescribed in the original publication [5].
Co-expression networks from the adjacency matrices
of healthy and dystrophic samples were generated
using the “TOMsimilarity” function available via
WGCNA. Hierarchical clustering on the topological
dissimilarity (1-TOM) was performed using the func-
tion “flashClust”. The tree cut height was dynamically
determined using the function “cutreeDynamic” in
WGCNA, for identifying modules in each of our net-
works. Additional files 4 and 5 provide a list of all
genes identified in each of the networks (healthy and
dystrophic respectively) and their corresponding mod-
ule assignments.
Preservation of modules
“Module preservation” or preservation statistics imple-
mented in WGCNA allows us to detect the conservation
of gene pairs between two networks (test and reference)
[7]. Briefly, three types of network based module preser-
vation statistics have been identified by this method,
namely
1) Density based preservation statistics: determine if
nodes remain highly connected in the test network.
Four independent measures account for this statistic.
2) Connectivity based preservation statistics determine
the extent to which connectivity patterns between
nodes in the reference network are similar to the
test network. Three independent measures of the
network account for this statistic.
3) Separability based preservation statistics determine if
network modules remain distinct from one another
in the test network.
Network based statistics employed by WGCNA do
not require identification of modules within the test
network to ascertain the conservation of reference
network modules within the test network. This is in
contrast to several existing methods that ascertain
module preservation as discussed in the original publi-
cation. The authors of the original publication have
shown that using this method it is possible to identify
sets of preserved co-expression across species.
As these statistics measure distinct aspects of module
preservation, two composite measures have been defined
1) Median rank: A composite measure that is based on
observed preservation values and is less dependent
on module sizes. It is defined as the mean of median
ranks computed for connectivity and densitymeasures of each module (0.5
(medianRankconnectivity + medianRankdensity).
2) Zsummary: A permutation based composite Z statistic
that is used to assess the significance of observed
statistics and is defined as the mean of Z scores
computed for density and connectivity measures
(0.5(Zdenstiy + Zconnectivity)). An associated empirical
p-value is also calculated by the algorithm.
We utilize median rank to identify module preserva-
tion and Zsummary to assess significance of module pres-
ervation via permutation testing. Based on the number
of modules within each of our networks, a median rank
of 8 was chosen as a cutoff to detect weak preservation.
Permutation was performed 200 times given the compu-
tational complexity involved for our network sizes.
Based on the thresholds prescribed in [7], modules with
a Zsummary score >10 indicate preservation, 2 to 10 indi-
cate weak to moderate preservation and <2 indicate no
preservation in the permutations.
Network specific gene pairs
Condition specific interactions for a given pair of genes i
and j was defined as [17]:
Specificitycond1 ¼
TOMij cond1ð Þ
TOMij cond1ð Þ þ TOMij cond2ð Þ
Where, TOMij (cond). is the normalized TO for the
gene pairs i-j in the given condition (healthy or disease).
We considered gene pairs to be condition specific, if
the specificity was >0.95 and were in the top 1% of the
gene pairs ranked on TOM similarity in any given mod-
ule. Number of edges in an undirected network is com-
puted as n(n-1)/2, where n is the number of nodes.
Considering the top 1% allowed us to focus only on the
strongest co-expression patterns within the module, ra-
ther than noise.
Enrichment analysis and visualization
The results presented correspond to the top term identi-
fied in the highest-ranking cluster (as of this analysis)
using the annotation clustering feature available in DA-
VID [31], with Gene Ontology’s Biological process func-
tional annotations. Additional files 6 and 7 provide the
top 3 functional annotation clusters identified for each
of the modules within the healthy and dystrophic net-
works respectively. Cytoscape [32] and Bioconductor
[33] were utilized for generating the figures in this
paper.
Availability of supporting data
The data sets supporting the results of this article are pub-
lished data sets available through the Gene expression
Mukund and Subramaniam BMC Research Notes  (2015) 8:182 Page 9 of 10omnibus repository, [GSE6011 http://www.ncbi.nlm.nih.
gov/geo/query/acc.cgi?acc=GSE6011].
Additional files
Additional file 1: Hierarchical clustering results for the a) Healthy
(normal) Network and b) Dystrophic (DMD) network: The upper
section represents the cluster dendrogram of the differentially
expressed genes identified for a) and b). The lower section (bar
charts) indicates the modules identified and their respective sizes after
hierarchical clustering. Each module is represented by the same colors in
the dendrogram for ease of visualization.
Additional file 2: This file shows the observed preservation
statistics computed using “modulePreservation” in WGCNA: The
preservation of the modules of the healthy network (NRML-
reference network) are identified in the entire dystrophic network
(DMD- test network).
Additional file 3: This file shows the observed preservation statistics
computed using “modulePreservation” in WGCNA: The preservation
of the modules of the dystrophic network (DMD- reference network)
are identified in the entire healthy network (NRML- test network).
Additional file 4: This .csv file provides the list of all genes, their
entrez ids and a corresponding module assignment vector. Module
names as colors, identifiable by WGCNA are also provided for the healthy
network.
Additional file 5: This .csv file provides the list of genes, their
entrez ids and a corresponding module assignment vector. Module
names as colors, identifiable by WGCNA are also provided for the
dystrophic network.
Additional file 6: This file provides the top 3 functional annotation
clusters identified using DAVID, for each module of the healthy
network.
Additional file 7: This file provides the top 3 functional annotation
clusters identified using DAVID, for each module of the dystrophic
network.
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